CODA THERAPEUTICS LTD has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OPEXA PHARMACEUTICALS INC, WHOLESOME BIOPHARM PTY LTD and COPENHAGEN UNIVERSITY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 2 | |
#4 | Hong Kong | 1 | |
#5 | Hungary | 1 | |
#6 | Japan | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change mitigation in goods production | |
#5 | Peptides | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Becker David L | 14 |
#2 | Green Colin R | 14 |
#3 | Green Colin Richard | 1 |
#4 | Becker David Laurence | 1 |
#5 | Green Colin | 1 |
#6 | Becker David | 1 |
Publication | Filing date | Title |
---|---|---|
AU2016203204A1 | Anti-connexin compounds and uses thereof | |
AU2013216578A1 | Anti-connexin compounds and uses thereof | |
EP2662088A2 | Anti-connexin compounds and uses thereof | |
US7098190B1 | Formulations comprising antisense nucleotides to connexins |